Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Olfactory bulb and olfactory sulcus depths are associated with disease duration and attack frequency in multiple sclerosis patients.
Ligands for Ser/Thr phosphoprotein phosphatases: a patent review (2005-2015).
Inherited and acquired disorders of myelin: The underlying myelin pathology.
CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.
Pain-related mood influences pain perception differently in fibromyalgia and multiple sclerosis.
Disruption of Myelin Leads to Ectopic Expression of KV1.1 Channels with Abnormal Conductivity of Optic Nerve Axons in a Cuprizone-Induced Model of Demyelination.
Liposomal corticosteroids for the treatment of inflammatory disorders and cancer.
Stabilometric assessment of context dependent balance recovery in persons with multiple sclerosis: a randomized controlled study.
Economic impact of multiple sclerosis in Italy: focus on rehabilitation costs.
Simvastatin in patients with progressive multiple sclerosis.
Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
Differential expression and regulatory roles of FABP5 and FABP7 in oligodendrocyte lineage cells.
Goodbye to all that: a short history of CCSVI.
Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.
Multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model.
Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis.
Can somatosensory evoked potentials predict disease course in early multiple sclerosis patients?
Multiple Sclerosis in the Levant: A Regional Consensus Statement.
Changing face of multiple sclerosis in the United kingdom 1990-2010. An incidence and prevalence study.
Finding the missing link in neuromyelitis optica presenting with recurrent transverse myelitis flares.
Validity of an Observation Method for Assessing Pain Behavior in Individuals With Multiple Sclerosis.
A Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple Sclerosis.
Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab.
Relapsing multiple sclerosis patients can look to second oral agent.
Pages
« first
‹ previous
…
400
401
402
403
404
405
406
407
408
…
next ›
last »